The Preuss Foundation Monoclonal Antibody Research on Brain Tumors Seminar II

April 1-2, 1988
La Jolla, California

Darell D. Bigner, M.D., Ph.D. - Chairperson
Duke University Medical Center
Durham, North Carolina

Luther W. Brady, M.D.
Hahnemann University Hospital
Philadelphia, Pennsylvania

G. Yancey Gillespie, Ph.D.
University of Alabama, Birmingham
Birmingham, Alabama

Ingegerd Hellstrom, M.D.
Oncogen Company
Seattle, Washington

Dorothee Herlyn, D.V.M.
Wistar Institute
Philadelphia, Pennsylvania

Rakesh K. Jain, Ph.D.
Carnegie Mellon University
Pittsburgh, Pennsylvania

Steven M. Larson, M.D.
Memorial Sloan-Kettering Cancer Center
New York, New York

Clause Meares, Ph.D.
University of California, Davis
Davis, California

Joseph Moksal, Ph.D.
Montefiore Medical Center
Durham, North Carolina

Edward A. Neuwelt, M.D.
Oregon Health Sciences University
Portland, Oregon

Stanley E. Order, M.D.
Johns Hopkins University Oncology Center
Baltimore, Maryland

Roger J. Packer, M.D.
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

Ralph A. Reisfeld, Ph.D.
Scripps Clinic and Research Foundation
La Jolla, CA

Mark Rosenblum, M.D.
University of California, San Francisco
San Francisco, California

Patrick J. Scannon, M.D., Ph.D.
XOMA Corporation
Berkeley, California

Martin Schrappe, M.D., Ph.D.
Scripps Clinic and Research Foundation
La Jolla, California

Peter Senter, Ph.D.
Oncogen Company
Seattle, Washington

Thomas A. Waltz, M.D.
Scripps Clinic and Research Foundation
La Jolla, California

Moody D. Wharam, M.D.
John Hopkins Oncology Center
Baltimore, Maryland

Carol J. Wilkstrand, Ph.D.
Duke University Medical Center
Bronx, New York

David V. Woo, Ph.D.
Hahnemann University Hospital
Philadelphia, Pennsylvania

Michael Zalutsky, Ph.D.
Duke University Medical Center
Durham, North Carolina

CONTACT

© 2019 The Preuss Foundation, Inc.

2223 Avenida de la Playa, Ste. 220

La Jolla, CA 92037

Tel 858-454-0200